Purpose: e aim of the present study was to evaluate the average sleeping energy expenditure (EE) levels using the SenseWear Armband (SWA) in patients with overt and subclinical hypothyroidism.
Hypothyroidism is a relatively common problem worldwide. It o en has an insidious onset and is relatively asymptomatic. It occurs in two forms: overt and subclinical. Overt hypothyroidism is characterized by a marked elevation of the thyroidstimulating hormone (TSH) level with decreased levels of free throxine (f T4) and free triiodothyronine (f T3), whereas subclinical hypothyroidism (sHT) is de ned as having serum f T4 levels within the normal range and elevated supra normal serum TSH levels [1] [2] [3] . yroid activity is related to energy expenditure (EE), and increased thyroid activity is able to increase basal metabolism. Consequently, decreased thyroid activity reduces basal metabolism and usually presents as an increase in body weight [4, 5] .
Human 24 h energy expenditure has three major components: the resting EE, the thermic e ect of food, and the energy cost of physical activity [6] . e basal metabolic rate is di cult to measure in most situations, except perhaps during sleep, because EE increases above basal levels as a result of the energy cost of arousal [2] .
e SenseWear Pro Armband (SWA) is a recently developed portable device used to assess EE. It is worn on the upper arm (usually the dominant side) over the triceps muscle, and it monitors various physiological and movement parameters. e SWA also provides estimates of the intensity, frequency and duration of a physical activity [7, 8] . e metabolic equivalent of task (MET) represents the intensity of energy cost of physical activities as multiples of the resting metabolic rate. e SWA device has been validated in free-living adults, children and clinical patients [9] [10] [11] [12] [13] [14] [15] . Additionally, previous studies have reported that the SWA is highly reliable at estimating the EE at rest [7, 13, 16, 17] .
Although the SWA device has been used and validated in the various situations mentioned above, there have been no clinical research studies to demonstrate the feasibility of the SWA to measure and monitor EE in patients with hypothyroidism. Because the daily EE level varies from person to person, the aim of the present study was to evaluate the average sleeping EE levels using the SWA device in patients with overt and subclinical hypothyroidism.
Materials and Methods

Study design and patients
is prospective study was conducted at the Harran University School of Medicine, Sanliurfa, Turkey. Prior to subject recruitment, the study protocol was reviewed and approved by the local ethics committee, in accordance with the ethical principles for human investigations, as outlined by the Second Declaration of Helsinki, and written informed consent was obtained from all the patients. From January-2011 to October-2011, 30 patients with overt hypothyroidism, 30 patients with sHT and 30 age-and gender-matched healthy volunteers were recruited to the study.
Hypothyroid patients were divided into two groups: group 1 (n = 30) consisted of patients with overt hypothyroidism and group 2 (n = 30) consisted of patients with sHT. Finally, group 3 (n = 30) consisted of healthy subjects. e exclusion criteria were as follows: recent acute infectious illness; any in ammatory or in ltrative disorder; any evidence of liver, kidney, or respiratory disease; diabetes mellitus; malignancy; use of any systemic drug that might have a ected the SWA or the thermoregulatory process and would a ect their bodyweight or metabolism; regular alcohol use; smokers; pregnancy; depression; sleep disorders; and psychiatric or neurological disorders. None of the patients had problems with adaptation to the devices used for assessment. e average EE and METs values during sleep of all hypothyroid participants were analyzed at baseline and at the end of the study. Data were also obtained from the healthy subjects at baseline.
Baseline de nitions and measurements
Height and weight were measured according to standardized protocols. Body mass index was calculated as the weight in kilograms divided by the height in meters squared (kg/m2). Blood pressure was measured using a mechanical sphygmomanometer in the medical o ce setting. For each subject, a er being seated comfortably for 15 minutes, the average of three blood pressure measurements was calculated. Body compositions were assessed with bioelectrical impedance analysis (BF 510, Omron Healthcare Co. Ltd., Kyoto, Japan).
Biochemical analysis
All of the blood samples were drawn from a large antecubital vein without interruption of the venous ow using a 19-gauge butter y needle connected to a plastic syringe. Twenty milliliters of blood was drawn, with the rst few milliliters discarded. Ten milliliters of blood was used for baseline routine laboratory tests. TSH, f T3 and f T4 levels were analyzed using an electrochemiluminescence immunometric assay (ECLIA) method with a Roche Elecsys E170 immuno-analyzer (Roche Diagnostics, Burgess Hill, UK). Serum urea, creatinine, fasting blood glucose, aspartate aminotransferase, alanine aminotransferase, triglycerides, total cholesterol, and high-density and low-density lipoprotein cholesterol levels were determined using commercially available assay kits (Abbott, Abbott Park, USA) with an auto-analyzer (Abbott, Abbott Park, USA). 
Conclusion
is is the rst published report that evaluates the average sleeping EE using the SWA device in patients with hypothyroidism. Contrary to what has been previously reported [19, 20] the main ndings of the present study showed that (i) the average sleeping EE and METs values between hypothyroid patients and healthy individuals were similar at baseline and (ii) a er achievement of the euthyroid state, the average sleeping EE and METs values did not change in the patients with hypothyroidism.
ere is considerable interest in the habitual physical activity levels and total EE of contemporary humans given the burden of inactivity-related disorders (e.g., cardiovascular disease, obesity, hypertension, type 2 diabetes and hyperlipidemia). erefore, a need for nonintrusive, accurate and valid methods for the measurement of physical activity and prediction of EE is warranted to address important health issues [12, 21] . e doubly-labeled water method, indirect calorimetry and metabolic carts are considered to be the gold standard techniques for EE assessment [22, 23] ; however, these techniques cannot easily assess free-living subjects in everyday life because of their methodological complexity, limited practicality and/or high cost [24] . e SWA is a valid, reliable, portable, practical and easily accessible device that reports total and active EE, METs values, duration and quanti cation of physical activity, body position, sleep e ciency, and sleep duration. Furthermore, the SWA relies more on subject characteristics, such as age, gender and weight, to calculate the resting metabolic rate, and it is not sensitive to small changes in EE from day to day [13, 25] . Modulation of the resting EE by thyroid hormones is well recognized in humans and rodents [2, 26] . In vivo assessment of the e ects of thyroid hormones on total EE is not easy. Because of the di culty in reaching the basal metabolic rate under most measurement situations, the resting metabolic rate is frequently determined using the same measurement conditions stated for determining the basal metabolic rate. For these reasons, we used SWA devices and chose the sleeping time to determine the metabolic activities of the subjects in our study.
It has been known for over a century that thyroid hormones stimulate the rate of metabolism and is a primary regulator of energy homeostasis in both energy intake and expenditure. It has also been known for many years that the resting EE is highly responsive to thyroid hormones. Furthermore, it is known that increased thyroid activity accompanies increased basal metabolism or vice versa: many thyrotoxic patients show increased physical activity and, conversely, many hypothyroid patients complain of lethargy. e mechanisms through which the thyroid hormone is related to the alterations in energy homeostasis and leads to changes in metabolism and molecular pathways have not been clearly identi ed and remain incompletely understood [4, [26] [27] [28] [29] . In this study, we did not detect a di erence in energy expenditure between patients with hypothyroidism and healthy subjects. Furthermore, treatment of the hypothyroidism did not change the metabolic rate of the patients a er achieving a euthyroid state.
To our knowledge, the e ects of thyroid hormones and the di erent states of thyroid disease on distinct components of EE have not been studied before. Our ndings may add data to the information that is lacking in this eld. Although it has been known for over a century that the metabolic rate is decreased in hypothyroidism, the mechanism of this e ect is not clearly described and remains controversial. Although the reliability and validity of the SWA device, which was used in the present study, has been demonstrated, the present results should be interpreted with caution because the sample size is small and our ndings require further validation. erefore, these results should be veri ed with large-scale, multicenter prospective cohort studies that are conducted using modern technologies and methods.
